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Here, we report on the first sequence-confirmed case of infection 
with the new influenza A(H1N1) virus in Germany. Two direct 
contacts of the patient were laboratory-confirmed as cases and 
demonstrate a chain of direct human-to-human transmission.
A patient in his 30s was admitted to the department of internal 
medicine of a district hospital in southern Germany, on 24 April 
2009 with influenza symptoms. Two days earlier, he had returned 
from a vacation in Mexico. He presented with fever up to 40° C, 
cough and dyspnoea. Headache and myalgia were not present. In 
addition, this patient had an unrelated, previously undiagnosed 
chronic disease. He was isolated on the morning of 27 April, and 
fever and dyspnoea resolved during that day. Since the evening 
of that day, he has been treated with oseltamivir. Because of his 
underlying medical condition he was transferred to the University 
Medical Centre on 28 April, where he has been in stable condition 
until present, with no further clinical signs of influenza.
Laboratory analysis
On 27 April 2009, the Laboratory of Medical Microbiology and 
Hygiene at the University of Regensburg Medical Center received 
a nose and throat swab of the patient for influenza PCR, because 
an infection with the new influenza A(H1N1) strain was suspected 
[1,2].
TaqMan-PCR for an 86 bp fragment of the M1 matrix protein 
gene was performed on the same day and was negative for influenza 
B, but weakly positive for influenza A (102-103 copies from 1 ml 
of swab extraction buffer). The two involved hospitals and health 
authorities were informed immediately. The primers used (set A, 
see Table) were part of an in house TaqMan-PCR system designed 
for conventional influenza A strains. 
Sequencing of this PCR product on 28 April showed that 
45 bp excluding the primers were identical to the California 
04/2009 H1N1 isolate from the current outbreak (GenBank entry 
FJ966085.1). The 45 bp sequence differed in three nucleotide 
T a b l e
Oligonucleotide primers used for amplification and sequencing
A




5’-GYT CTC ATG GAR TGG 
CTA AAG ACA-3’
backward primer (InflA-MA2-2)
5’-GGC ACG GTG AGC GTG AA-3’
TaqMan probe (InflA-MA-So-2b)
FAM-5’-ACC AAT CCT GTC ACC TCT GAC 
TAA GGG GA-3’-TAMRA
B




5’-ACC GAG GTC GAA ACG 
TA-3’
outer backward primer 
(MA-c_2)
5’-CGA TCA AGA ATC CAC AAT 
ATC-3’
inner forward primer (MA-c_3)
5’-CAG AGA CTT GAA GAT GTC TTT G-3’
inner backward primer
(MA-c_4)
5’-TTC TGR TAG GYC TGC AAA TT-3’
C
Primers targeting HA gene 
sequencing
outer forward primer 
(H1N1_HA_F1)
5’-CCG CAA ATG CAG ACA 
CAT TA-3’
outer backward primer 
(H1N1_HA_R1)
5’-CCC ATT AGA GCA CAT CCA 
GAA-3’
inner forward primer (H1N1_HA_F2)
5’-TGC GAA CAA TTC AAC AGA CA-3’
inner backward primer
(H1N1_HA_R2)




specific TaqMan PCR system [3]
forward primer (H1SWS)
5´-CAT TTG AAA GGT TTG 
AGA TAT TCC C-3´
backward primer (H1SWAs1)
5´-GGA CAT GCT GCC GTT ACA 
CC-3´
TaqMan probe (H1SWP)
FAM-5`-ACA AGT TCA TGG CCC AAT CAT 
GAC TCG-3´-BBQ
TaqMan PCR system A had been designed for conventional influenza A strains. Due to the two distinct nucleotides in the probe region, this assay may 
slightly underestimate the viral load of the novel influenza A(H1N1) strain. Primer system B had been designed for conventional influenza A strains. It 
does not exactly fit the novel influenza A(H1N1) strain in several positions, but worked well for sequencing the first German isolate.
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positions from conventional human influenza A strains, two of them 
within the TaqMan probe region. This was considered a strong 
indication for infection with the new virus.
A larger 600 bp PCR fragment of the matrix protein gene was 
sequenced on the same evening, using primer set B (see Table). 
In a BLAST search it was 100% identical over a stretch of 597 
nucleotides with the above mentioned California isolate, but 
differed in at least 5% from annotated human influenza A(H1N1) 
strains. Conventional porcine influenza H3N2, but also H1N1 
strains, were generally more closely related to our sequence than 
human strains. 
Therefore, we considered this isolate as the first proven case 
of the new influenza A(H1N1) in Germany. Health authorities 
and physicians were immediately informed. The 597 nucleotide 
sequence was submitted to GenBank on the same day (FJ970928*).
In parallel, a 1,446 bp fragment of the haemagglutinin gene 
was amplified and sequenced using primer set C (see Table), and 
submitted to GenBank (FJ974021) on 30 April. This sequence 
was identical to two California strains (GenBank FJ969511 and 
FJ966952) isolated in the current worldwide outbreak, with the 
exception of only one nucleotide mismatch. In addition a 1,109 
bp sequence of the neuraminidase gene of our first isolate has 
meanwhile been deposited in GenBank (FJ984953) and in the 
database of the Global Initiative on Sharing Avian Influenza Data 
(GISAID). It had 100% similarity with the Texas/04 and Texas/05 
isolates (FJ981614 and FJ966969).
Contact testing
In the presumed incubation time, the index patient had several 
contacts of varying closeness and duration before his admission 
to hospital. Contact tracing and testing through the public health 
authorities was started immediately. Detailed data on the contacts 
of the index patient before entering the hospital will be reported 
by the public health authorities.
Before the patient was isolated on the morning of 27 April under 
suspicion of new influenza, he had an estimated 19 close contacts 
among staff at the district hospital and one patient who stayed 
in the same twin room as the index case in the district hospital.  
One of the nurses who had close contact with him has so far 
tested positive for the new influenza A (H1N1), and had influenza 
symptoms for a period of two days on 26-27 April. This case 
received oseltamivir treatment and stayed isolated at home until 5 
May when she had tested negative for the new influenza A(H1N1) 
strain.
All other contacts among the district hospital staff and 
additional hospital staff who had not had contact with the index 
patient (a total of 32 people) were tested one or two times and 
have remained PCR-negative and healthy as of 7 May.
All 32 were tested and offered oseltamivir prophylaxis, but only 
a minority accepted the treatment. Contacts among the staff at the 
University Medical Centre remained healthy and were not tested, 
because the isolation care of the patient was continued without 
interruption from the beginning.
A sputum sample of the patient sharing the room with the index 
case was found positive on 29 April in an influenza A-specific 
TaqMan-PCR assay (set A, see Table). A second TaqMan-PCR 
assay, specific for the new influenza A(H1N1) strain (primer set 
D, see Table), was found positive on the same day. The patient 
was isolated and treated with oseltamivir in the afternoon of 29 
April, and health authorities were informed. He suffered only minor 
influenza-like symptoms. 
Both this and the index patient have since tested negative for the 
new influenza A(H1N1) strain three times and have been released 
from isolation. Due to additional chronic diseases unrelated to 
influenza, however, they have not been released from the hospital 
yet.
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